AccuVein to Display Leading Vein Finding Technology at Upcoming Aesthetic Meetings
Long Island, NY (PRWEB) April 27, 2017 -- AccuVein Inc. (http://www.accuvein.com), the global leader in vein visualization, will be displaying their award winning AV400 device at The Aesthetic Meeting from April 29-May 1 in San Diego, CA and the Symposium for Cosmetic Advances and Laser Education (SCALE) from May 4-7 in Nashville, Tennessee.
AccuVein’s flagship product, the AV400, helps healthcare professionals locate veins by displaying a map of the patient’s vasculature directly on the surface of the skin. Locating peripheral vasculature allows aesthetic clinicians to avoid veins which can help minimize bruising that may result from injectable procedures. The device also helps with identifying and accessing veins for sclerotherapy procedures.
“A growing number of aesthetic physicians, including many top doctors, have embraced AccuVein vein visualization for their procedures,” said Monica Jugovic, AccuVein Senior Marketing Manager, “These clinicians recognize the enormous benefit of sparing patients the tell-tale signs of having had an injectable procedure. When social downtime is reduced, everyone is happy!”
Vein location also addresses the FDA’s safety alert warning that “serious injuries may occur due to unintentional injection of soft tissue filler into blood vessels in the face”, by identifying the facial veins, thereby allowing them to be avoided. There are approximately two million soft filler procedures performed annually in the U.S.
AccuVein can be found at booth #110 at The Aesthetic Meeting and booth #16 at SCALE. Additional aesthetic meetings that AccuVein will be attending can be found here.
About AccuVein Inc.
AccuVein Inc. is the global leader in vein visualization technology. AccuVein’s flagship product, the AV400, is the world’s only hand-held, non-contact vein illumination solution. The device has won numerous awards including the prestigious Prism Award for Photonics Innovation. Healthcare professionals see a map of peripheral veins directly on the skin’s surface with the goal of accessing or avoiding veins. It is built on proprietary technology embodied in its growing patent portfolio on a broad range of imaging and medical diagnostic technologies. AccuVein is in use at more than 5,000 facilities and available for sale in over 130 countries worldwide. To see a demonstration of AccuVein in action, please visit http://www.accuvein.com.
Heidi Siegel, accuvein, http://www.accuvein.com, +1 631-367-0393 Ext: 106, [email protected]
Share this article